Back
Phathom Pharmaceuticals Vs. Xeris Biopharma Holdings Industry Stock Comparison
Buy
71
PHAT
Phathom Pharmaceuticals
Last Price:
10.03
Seasonality Move:
-5.21%
Buy
69
XERS
Xeris Biopharma Holdings
Last Price:
1.88
Seasonality Move:
-5.66%
Buy
71
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.04. The Score for PHAT is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $1.89. The Score for XERS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing slight selling pressure.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $1.89
The current trend is relatively stagnant and XERS is experiencing slight buying pressure.
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 55.02 | Buy |
| Chaikin Money Flow: | -158769 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.1 - 10.82) | Buy |
| Bollinger Bands (100): | (7.52 - 10.26) | Buy |
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 47.39 | Sell |
| Chaikin Money Flow: | 124991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.74 - 2.02) | Buy |
| Bollinger Bands (100): | (1.92 - 2.78) | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.36 | Buy |
| 20-day SMA: | 9.84 | Buy |
| 50-day SMA: | 9.78 | Buy |
| 200-day SMA: | 10.02 | Buy |
| 8-day EMA: | 9.52 | Buy |
| 20-day EMA: | 9.63 | Buy |
| 50-day EMA: | 9.52 | Buy |
| 200-day EMA: | 9.7 | Buy |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.78 | Buy |
| 20-day SMA: | 1.83 | Buy |
| 50-day SMA: | 2.18 | Sell |
| 200-day SMA: | 2.18 | Sell |
| 8-day EMA: | 1.81 | Buy |
| 20-day EMA: | 1.86 | Buy |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 2.18 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.75 per share, and an increase next year of $1.24 per share.
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Phathom Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xeris Biopharma Holdings Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||